AstraZeneca Eyes Full U.S. Approval For Covid Shot This Year, Skipping Faster Emergency AuthorizationForbes • 07/29/21
AstraZeneca Stock Gains As Q2 Earnings Beat Forecasts, Clocks $894M In COVID-19 Vaccine SalesBenzinga • 07/29/21
No Increased Risk Of Blood Clots After Second Dose Of AstraZeneca's COVID-19 Shot, Study ShowsBenzinga • 07/28/21
Hutchmed Stock Gains On Kick Starting Mid-Stage Gastric Cancer Trial With AstraZeneca's OrpathysBenzinga • 07/28/21
AstraZeneca says Alexion receives recommendation to use rare blood disorder drug in kidsProactive Investors • 07/26/21
Real-World Data In Canada Shows AstraZeneca's COVID-19 Jab Is Over 80% Effective Against VariantsBenzinga • 07/23/21